|

CELLDEX THERAPEUTICS INC (CLDX)

US15117B2025 - Common Stock

31.43  -0.4 (-1.26%)

After market: 31.43 0 (0%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to CLDX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 56.83. This target is 80.81% above the current price.
CLDX was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CLDX.
In the previous month the buy percentage consensus was at a similar level.
CLDX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 31.4319.1966.3056.8384.00 - -38.94% 110.94% 80.81% 167.26%
Up and Down Grades
Date Firm Action Rating
2023-11-10 Wells Fargo Upgrade Underweight -> Equal-Weight
2023-11-06 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-03 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-10-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-27 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-22 Wells Fargo Initiate Underweight
2023-08-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-10 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-09 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-31 HC Wainwright & Co. Reiterate Buy
2023-05-05 Cantor Fitzgerald Maintains Overweight
2023-05-05 HC Wainwright & Co. Reiterate Buy
2023-03-22 HC Wainwright & Co. Reiterate Buy
2023-03-01 HC Wainwright & Co. Reiterate Buy
2023-02-27 HC Wainwright & Co. Reiterate Buy
2022-11-11 Guggenheim Maintains Buy
2022-08-09 SVB Leerink Maintains Outperform
2022-07-01 HC Wainwright & Co. Maintains Buy
2021-09-17 Jefferies Initiate Buy
2021-09-13 HC Wainwright & Co. Maintains Buy
2021-09-10 SVB Leerink Initiate Outperform
2021-08-06 HC Wainwright & Co. Maintains Buy
2021-07-22 Guggenheim Initiate Buy
2021-07-12 HC Wainwright & Co. Maintains Buy
2021-02-23 HC Wainwright & Co. Maintains Buy